Status:
COMPLETED
Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
Lead Sponsor:
Haukeland University Hospital
Conditions:
Vestibular Schwannoma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the outcome of patients with vestibular schwannomas in two groups of randomised to either radiosurgery or expectation. The optimal treatment for a small vestib...
Detailed Description
Study design and purpose: Design: Randomised study blinded to observer on primary endpoint (tumor volume). Intention-to-treat, ie patients who cross over from conservative to GKRS group during the st...
Eligibility Criteria
Inclusion
- Vestibular schwannoma diagnosed by MRI of less than 6 months.
- Diameter 4-20mm. Willing to participate. Age 18 -70 years.
Exclusion
- Dementia
- Active malignant disease
- Type II neurofibromatosis in patient or first grade relative.
- Other severe co-morbidity
- Type 2 neurofibromatosis in patient or first-grade relative
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02249572
Start Date
October 1 2014
End Date
October 1 2021
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland Unviersity Hospital
Bergen, Norway, 5021